![]() PDL 15 Oct 2015 Paid | Final | GBX95.73 Per Share |
18 Feb 2025 Date | | - Cons. EPS | - EPS |
13 Nov 2024 Date | | - Cons. EPS | - EPS |
26 Sep 2024 Date | | - Cons. EPS | - EPS |
24 Sep 2024 Date | | - Cons. EPS | - EPS |
16 Jul 2024 Date | | - Cons. EPS | - EPS |
![]() PDL 15 Oct 2015 Paid | Final | GBX95.73 Per Share |
18 Feb 2025 Date | | - Cons. EPS | - EPS |
13 Nov 2024 Date | | - Cons. EPS | - EPS |
26 Sep 2024 Date | | - Cons. EPS | - EPS |
24 Sep 2024 Date | | - Cons. EPS | - EPS |
16 Jul 2024 Date | | - Cons. EPS | - EPS |
Drug Manufacturers—Specialty & Generic Industry | Healthcare Sector | Mr. Carmine Marotta CEO | LSE Exchange | BMG702782084 ISIN |
Canada Country | - Employees | 15 Oct 2015 Last Dividend | 29 Nov 2021 Last Split | - IPO Date |
Indiva Limited is a Canada-based company specializing in the cannabis industry. Its business operations encompass the production, processing, and sale of cannabis and cannabis-related products across Canada. Indiva offers its products under several brands, namely INDIVA, Indiva Life, and Artisan Batch, catering to a wide range of consumer preferences. The company distinguishes itself by producing and distributing several popular licensed products, including Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products, through strategic licensing agreements and partnerships. Having its base in Ottawa, Canada, Indiva leverages its geographical location to serve the Canadian market effectively, ensuring the availability of its diverse product portfolio to consumers nationwide.